Konsultacja z Receptą
Doxorubicinum Accord, 2 mg/ml, is a medication used for infusion after dilution, and is commonly referred to as "Doxorubicinum Accord". It belongs to a group of drugs called anthracyclines, which are also known as anti-cancer or chemotherapy drugs. These drugs are used to treat various types of cancer, with the aim of delaying or stopping the growth of cancer cells. To achieve better results and reduce side effects, a combination of different anti-cancer drugs is often used. Doxorubicinum Accord is used to treat the following types of cancer: breast cancer connective tissue, ligament, bone and muscle cancer (sarcoma) stomach or intestinal cancer lung cancer lymphomas - tumors of the immune system leukemia, a cancer that causes disruptions in blood cell production thyroid gland cancer advanced ovarian and uterine corpus cancer (endometrial or uterine cancer) bladder cancer advanced immature nerve tumor (neuroblastoma) (a cancer of nerve cells that usually occurs in children) malignant kidney tumor in children (Wilms tumor) multiple myeloma (bone marrow cancer).
Doksorubicyna jest wskazana do stosowania w leczeniu następujących chorób nowotworowych;
Przykłady obejmują:
Doksorubicynę często stosuje się w schemacie chemioterapii skojarzonej z innymi lekami cytotoksycznymi.
Doxorubicinum Accord
- ChPL (Charakterystyka Produktu Leczniczego)
Pobierz
Warszawa
Wrocław
Poznań
Kraków
Łódź
Katowice
Gdańsk
Szczecin
Opole
Rzeszów
Bydgoszcz
Lublin
Gorzów Wielkopolski
Białystok
Kielce
Olsztyn
Konsultacja z Receptą
